Janar Sathananthan, Ole De Backer, and Michael Reardon dive into the newest findings on TAVR from the late-breaking ACURATE IDE trial.

For the last decade, Erin D. Michos, MD (Johns Hopkins University School of Medicine, Baltimore, MD), has consistently posted updates to her feed on X (formerly Twitter) for her more than 30,000 ...

An increased risk of cardiovascular disease may be present as early as 30 years before a type 2 diabetes diagnosis is made, ...

The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

Written to offer advice where formal guidelines fall short, the document urges a balance between bleeding and ischemic risk.